Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.

<h4>Objective</h4>To model the resource implications of placental growth factor (PlGF) testing in women with suspected pre-eclampsia prior to 35 weeks' gestation as part of a management algorithm, compared with current practice.<h4>Methods</h4>Data on resource use from 1...

Full description

Bibliographic Details
Main Authors: Suzy Duckworth, Lucy C Chappell, Paul T Seed, Lucy Mackillop, Andrew H Shennan, Rachael Hunter
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0164276
id doaj-1ff335c1d9284d7e8586bfd1c6873f6e
record_format Article
spelling doaj-1ff335c1d9284d7e8586bfd1c6873f6e2021-03-04T12:31:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011110e016427610.1371/journal.pone.0164276Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.Suzy DuckworthLucy C ChappellPaul T SeedLucy MackillopAndrew H ShennanRachael Hunter<h4>Objective</h4>To model the resource implications of placental growth factor (PlGF) testing in women with suspected pre-eclampsia prior to 35 weeks' gestation as part of a management algorithm, compared with current practice.<h4>Methods</h4>Data on resource use from 132 women with suspected pre-eclampsia prior to 35 weeks' gestation, enrolled in a prospective observational cohort study evaluating PlGF measurement within antenatal assessment units within two UK consultant-led maternity units was extracted by case note review. A decision analytic model was developed using these data to establish the budget impact of managing women with suspected pre-eclampsia for two weeks from the date of PlGF testing, using a clinical management algorithm and reference cost tariffs. The main outcome measures of resource use (numbers of outpatient appointments, ultrasound investigations and hospital admissions) were correlated to final diagnosis and used to calculate comparative management regimes.<h4>Results</h4>The mean cost saving associated with the PlGF test (in the PlGF plus management arm) was £35,087 (95% CI -£33,181 to -£36,992) per 1,000 women. This equated to a saving of £582 (95% CI -552 to -£613) per woman tested. In 94% of iterations, PlGF testing was associated with cost saving compared to current practice.<h4>Conclusions</h4>This analysis suggests PlGF used as part of a clinical management algorithm in women presenting with suspected pre-eclampsia prior to 35 weeks' gestation could provide cost savings by reducing unnecessary resource use. Introduction of PlGF testing could be used to direct appropriate resource allocation and overall would be cost saving.https://doi.org/10.1371/journal.pone.0164276
collection DOAJ
language English
format Article
sources DOAJ
author Suzy Duckworth
Lucy C Chappell
Paul T Seed
Lucy Mackillop
Andrew H Shennan
Rachael Hunter
spellingShingle Suzy Duckworth
Lucy C Chappell
Paul T Seed
Lucy Mackillop
Andrew H Shennan
Rachael Hunter
Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.
PLoS ONE
author_facet Suzy Duckworth
Lucy C Chappell
Paul T Seed
Lucy Mackillop
Andrew H Shennan
Rachael Hunter
author_sort Suzy Duckworth
title Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.
title_short Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.
title_full Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.
title_fullStr Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.
title_full_unstemmed Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.
title_sort placental growth factor (plgf) in women with suspected pre-eclampsia prior to 35 weeks' gestation: a budget impact analysis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description <h4>Objective</h4>To model the resource implications of placental growth factor (PlGF) testing in women with suspected pre-eclampsia prior to 35 weeks' gestation as part of a management algorithm, compared with current practice.<h4>Methods</h4>Data on resource use from 132 women with suspected pre-eclampsia prior to 35 weeks' gestation, enrolled in a prospective observational cohort study evaluating PlGF measurement within antenatal assessment units within two UK consultant-led maternity units was extracted by case note review. A decision analytic model was developed using these data to establish the budget impact of managing women with suspected pre-eclampsia for two weeks from the date of PlGF testing, using a clinical management algorithm and reference cost tariffs. The main outcome measures of resource use (numbers of outpatient appointments, ultrasound investigations and hospital admissions) were correlated to final diagnosis and used to calculate comparative management regimes.<h4>Results</h4>The mean cost saving associated with the PlGF test (in the PlGF plus management arm) was £35,087 (95% CI -£33,181 to -£36,992) per 1,000 women. This equated to a saving of £582 (95% CI -552 to -£613) per woman tested. In 94% of iterations, PlGF testing was associated with cost saving compared to current practice.<h4>Conclusions</h4>This analysis suggests PlGF used as part of a clinical management algorithm in women presenting with suspected pre-eclampsia prior to 35 weeks' gestation could provide cost savings by reducing unnecessary resource use. Introduction of PlGF testing could be used to direct appropriate resource allocation and overall would be cost saving.
url https://doi.org/10.1371/journal.pone.0164276
work_keys_str_mv AT suzyduckworth placentalgrowthfactorplgfinwomenwithsuspectedpreeclampsiapriorto35weeksgestationabudgetimpactanalysis
AT lucycchappell placentalgrowthfactorplgfinwomenwithsuspectedpreeclampsiapriorto35weeksgestationabudgetimpactanalysis
AT paultseed placentalgrowthfactorplgfinwomenwithsuspectedpreeclampsiapriorto35weeksgestationabudgetimpactanalysis
AT lucymackillop placentalgrowthfactorplgfinwomenwithsuspectedpreeclampsiapriorto35weeksgestationabudgetimpactanalysis
AT andrewhshennan placentalgrowthfactorplgfinwomenwithsuspectedpreeclampsiapriorto35weeksgestationabudgetimpactanalysis
AT rachaelhunter placentalgrowthfactorplgfinwomenwithsuspectedpreeclampsiapriorto35weeksgestationabudgetimpactanalysis
_version_ 1714802231059939328